ID
24263
Descrizione
NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection
Keywords
versioni (1)
- 2017-07-28 2017-07-28 -
Titolare del copyright
GlaxoSmithKline
Caricato su
28 juli 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADO
GSK Study Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS NCT00079911
Similar models
GSK Study Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS NCT00079911
C0497156 (UMLS CUI [2])
C0012634 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])